Scientists at Michigan Medicine have made a significant breakthrough in treating nonalcoholic fatty liver disease (NAFLD), a ...
In the medical field, terminology not only guides clinical understanding and patient communication but also impacts research, ...
Consuming too much sugar can lead to dependency-like behaviours and serious health issues. Sugar activates the brain’s reward ...
Non-alcoholic fatty liver disease (NAFLD) is regarded as a manifestation of metabolic syndrome in the liver. This investigation was initiated to determine whether NAFLD has a relationship to ...
A recent study from Université Laval suggests that camu-camu, an exotic fruit native to the Amazon, may help address ...
AZoLifeSciences on MSN16d
What microbes tell us about Nonalcoholic Fatty Liver DiseaseRobust microbiome signatures enable more precise diagnoses and open up new therapeutic approaches for the treatment of NAFLD ...
Nat Clin Pract Gastroenterol Hepatol. 2009;6(1):18-19. Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases in the Western world. NAFLD is associated with chronic ...
A study revealed highly specific gut microbiome signatures for NAFLD, using machine learning to differentiate the disease ...
A study published in the Journal of Human Nutrition and Dietetics explores the association between legume consumption and the ...
近日，Journal of Diabetes and its Complications期刊发表的一项研究显示：在2型糖尿病（T2DM）合并非酒精性脂肪肝病（NAFLD）患者中，司美格鲁肽联合二甲双 ...
Actor Amitabh Bachchan advocates for a national campaign against non-alcoholic fatty liver disease, highlighting its severity and increasing prevalenc ...
肝脏巨噬细胞在调节肝细胞代谢和维持肝脏免疫耐受方面发挥核心作用。正常生理条件下，肝脏巨噬细胞倾向于 M2 表型，可通过分泌白细胞介素（IL）-4 和 IL-13 抑制炎症。然而，在 NAFLD 进展时，肝星状细胞激活、血液中脂多糖水平升高以及 FFA 激活炎症小体等变化，会刺激炎症发生，增加分泌促炎细胞因子的 M1 巨噬细胞比例。
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback